These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2366880)

  • 1. Cardiovascular effects of flesinoxan in anaesthetized and conscious dogs.
    Grohs JG; Fischer G; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1990 May; 341(5):472-5. PubMed ID: 2366880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and side effects of flesinoxan in conscious hypertensive dogs. Modulation by prazosin.
    Huber S; Grohs JG; Raberger G
    Eur J Pharmacol; 1991 Sep; 202(1):1-7. PubMed ID: 1786795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of anaesthesia on the haemodynamic and sympathoadrenal responses of the dog in experimental haemorrhagic shock.
    Adamicza A; Tárnoky K; Nagy A; Nagy S
    Acta Physiol Hung; 1985; 65(3):239-54. PubMed ID: 4013763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 1-adrenoceptor blockade and/or 5-HT1A agonism during treadmill exercise in dogs.
    Grohs JG; Fischer G; Huber S; Raberger G
    J Auton Pharmacol; 1991 Apr; 11(2):101-7. PubMed ID: 1675216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of the central nervous system in the systemic and regional hemodynamics of two centrally acting hypotensive drugs, flesinoxan and clonidine, in the rat.
    Dabiré H; Richer C
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):605-13. PubMed ID: 1724539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal functional responses to 5-HT1A receptor agonist, flesinoxan, in anaesthetized, normotensive rat.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1994 May; 112(1):214-8. PubMed ID: 8032644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits.
    Hof RP; Fozard JR
    Br J Pharmacol; 1989 Apr; 96(4):864-71. PubMed ID: 2568144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors.
    Wouters W; Tulp MT; Bevan P
    Eur J Pharmacol; 1988 May; 149(3):213-23. PubMed ID: 2842163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the cardiovascular effects and '5-HT syndrome' induced by MDL 73,975 and flesinoxan in the dog mediated by 5-HT1A receptors?
    Di Francesco GF
    Eur J Pharmacol; 1994 Sep; 262(3):205-15. PubMed ID: 7813585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat.
    Dreteler GH; Wouters W; Toorop GP; Jansen JA; Saxena PR
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):488-93. PubMed ID: 1711612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of intravenous pentazocine and cyclazocine in conscious, curarized-conscious, and anesthetized dogs.
    Küçukhüseyin C
    J Basic Clin Physiol Pharmacol; 2003; 14(3):235-55. PubMed ID: 14964736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo characterization of 5-HT1A receptor-mediated gastric relaxation in conscious dogs.
    Janssen P; Prins NH; Moreaux B; Meulemans AL; Lefebvre RA
    Br J Pharmacol; 2003 Nov; 140(5):913-20. PubMed ID: 14517177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Van den Buuse M
    Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of depressor-I, a hypotensive phospholipid from bovine brain, on systemic and arterial blood pressures of various species.
    Tsukatani H; Yamada S; Tokumura A; Itami T
    Jpn J Pharmacol; 1979 Oct; 29(5):695-705. PubMed ID: 295088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiovascular and renal functional responses to the 5-HT1A receptor agonist flesinoxan in two rat models of hypertension.
    Chamienia AL; Johns EJ
    Br J Pharmacol; 1996 Aug; 118(8):1891-8. PubMed ID: 8864520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
    Seki S; Sato K; Nakayama M; Murray PA
    Anesthesiology; 1997 Apr; 86(4):923-35. PubMed ID: 9105237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal functional responses to the 5-HT1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure.
    Chamienia AL; Johns EJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):215-20. PubMed ID: 8169828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and regional hemodynamic effects of the putative 5-HT1A receptor agonist flesinoxan in the cat.
    Dreteler GH; Wouters W; Saxena PR
    J Cardiovasc Pharmacol; 1989 Nov; 14(5):770-6. PubMed ID: 2481192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of clonidine and flesinoxan on blood pressure variability in conscious spontaneously hypertensive rats.
    Chaouche-Teyara K; Lacolley P; Challande P; Fournier B; Laurent S; Safar M; Dabiré H
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):241-4. PubMed ID: 9269953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.